Yongying CSI All-Index Medical Device Exchange-traded Open-ended Index Securities Investment Fund (abbreviation: Medical Device ETF, code 159883) announced its latest net value on November 14, down 3.09%.
The medical device ETF was established on April 22, 2021, and its performance is based on the return rate of the CSI All-Index Medical Device Index. The fund has returned -47.71% since its inception, -7.25% this year, 2.53% over the past month, -7.55% over the past year, and -34.27% over the last three years. In the past year, the fund ranked 2941/3259 in its peer group.
The fund manager is Chu Kefan. Chu Kefan has managed (or intends to manage) the fund since August 14, 2023, with a return of -6.04% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 300760 | Mindray Medical | 13.46% | 875021 | 256 million |
| 688271 | United Imaging Medical | 6.16% | 916724 | 117 million |
| 300896 Aimeike | :5.23%, | 422670 | ,99.5811 million | |
| 688617 | Huitai Medical | 4.12%, | 191542 | 78.4154 million |
| 300832 | new industries | 3.77% | 876424 | 71.8317 million |
| 002223 | Yuyue Medical | 3.37% | 1676300 | 64.1688 million |
| 600529 | Shandong Pharmaceutical Glass | 2.84% | 1854400 | 54.0001 million |
| 002432 | Jiu'an Medical | 2.71% | 1093900 | 51.5555 million |
| 300003 | Lepu Medical | 2.54% | 3673669 | 48.3822 million |
| 300529 | Jianfan Biotech | 2.33% | 1352588 | 44.2837 million |
Ticker Name
Percentage Change
Inclusion Date
